DAILYZ HEALTH NEWS

June 16, 2026 Evan Vega

Long daytime naps over 30 minutes linked to higher risk of fatty liver disease in people with type 2 diabetes, new ENDO 2026 data suggest

A study at ENDO 2026 found that type 2 diabetes patients who nap over 30 minutes have a higher risk of fatty liver disease.

Health

June 15, 2026 Evan Vega

Bangladesh measles outbreak death toll surpasses 650 children as WHO and UNICEF rush emergency vaccination support to curb regional spread

Bangladesh’s measles outbreak has killed over 650 children, prompting WHO and UNICEF to launch emergency vaccinations for young children.

Health

June 14, 2026 Evan Vega

FDA clears first gene-edited cell therapy for severe sickle cell disease, paving way for wider use of CRISPR-based treatments in US hospitals

The FDA approved CASGEVY™, the first CRISPR gene-edited cell therapy, for severe sickle cell disease patients 12 and older with recurrent crises.

Global Drug-Resistant Tuberculosis Emergency

Health

June 5, 2026 Evan Vega

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Health

June 4, 2026 Evan Vega

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

The Biden administration announced a plan to cap insulin out-of-pocket costs at $35 monthly for all insured Americans, expanding beyond Medicare.

Health

June 3, 2026 Evan Vega

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

As of mid-2026, the FDA has not approved any gene-editing therapies for type 1 diabetes, with such treatments still in preclinical stages.

Health

June 2, 2026 Evan Vega

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

A six-month trial in NEJM found hybrid closed-loop insulin pumps improved A1c and reduced severe hypoglycemia in type 1 diabetes patients.

Health

June 2, 2026 Evan Vega

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

The FDA has not approved RebiQuent for moderate to severe atopic dermatitis; current oral treatments include abrocitinib and upadacitinib.

Health

June 2, 2026 Evan Vega

UnitedHealth confirms ransomware attack exposed health data of 4.2 million patients, prompting federal cybersecurity probe

UnitedHealth’s Change Healthcare unit suffered a ransomware attack exposing data of 4.2 million patients; a $22 million ransom was paid.

Health

May 29, 2026 Evan Vega

New study links routine blood test marker changes to earlier detection of aggressive cancer

A study finds changes in two blood proteins enable over 90% accurate early detection and monitoring of aggressive glioblastoma brain cancer.

DAILYZ HEALTH NEWS

DAILYZ HEALTH NEWS

FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

HHS Awards Nearly $250 Million to Expand Mental Health and Addiction Treatment Services

Doctors Without Borders Worker Evacuated After Contracting Ebola in Democratic Republic of Congo Outbreak

FDA issues emergency use authorization for drugs to prevent and treat New World screwworm in dogs and cats

FDA approves first drug to treat Alexander disease, offering a targeted therapy for the ultra-rare, progressive neurodegenerative disorder in children

FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

HHS Awards Nearly $250 Million to Expand Mental Health and Addiction Treatment Services

Doctors Without Borders Worker Evacuated After Contracting Ebola in Democratic Republic of Congo Outbreak

FDA issues emergency use authorization for drugs to prevent and treat New World screwworm in dogs and cats

FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

HHS Awards Nearly $250 Million to Expand Mental Health and Addiction Treatment Services

Doctors Without Borders Worker Evacuated After Contracting Ebola in Democratic Republic of Congo Outbreak

FDA issues emergency use authorization for drugs to prevent and treat New World screwworm in dogs and cats

FDA approves first drug to treat Alexander disease, offering a targeted therapy for the ultra-rare, progressive neurodegenerative disorder in children

FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

HHS Awards Nearly $250 Million to Expand Mental Health and Addiction Treatment Services

Doctors Without Borders Worker Evacuated After Contracting Ebola in Democratic Republic of Congo Outbreak

FDA issues emergency use authorization for drugs to prevent and treat New World screwworm in dogs and cats

FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

HHS Awards Nearly $250 Million to Expand Mental Health and Addiction Treatment Services

Doctors Without Borders Worker Evacuated After Contracting Ebola in Democratic Republic of Congo Outbreak

FDA issues emergency use authorization for drugs to prevent and treat New World screwworm in dogs and cats

FDA approves first drug to treat Alexander disease, offering a targeted therapy for the ultra-rare, progressive neurodegenerative disorder in children

Long daytime naps over 30 minutes linked to higher risk of fatty liver disease in people with type 2 diabetes, new ENDO 2026 data suggest

Bangladesh measles outbreak death toll surpasses 650 children as WHO and UNICEF rush emergency vaccination support to curb regional spread

FDA clears first gene-edited cell therapy for severe sickle cell disease, paving way for wider use of CRISPR-based treatments in US hospitals

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

UnitedHealth confirms ransomware attack exposed health data of 4.2 million patients, prompting federal cybersecurity probe

New study links routine blood test marker changes to earlier detection of aggressive cancer